INVO News and Press, INVO BioScience Inc. From 04/17/24

A look at the top 10 most actives in the United States Jaguar Health Inc. (JAGX) fell 0.7% to $0.177 on volume of 56,661,669 shares INVO BioScience Inc. (INVO) rose 233.6% to $2.535 on volume of 49,222,014 shares WiSA Technologies Inc. (WISA) rose 51.8% to $9.26 on volume of 27,894,316 sh...

2024-04-17 06:32:26 ET DENVER, Colo., Apr 17, 2024 ( 247marketnews.com )- INVO Bioscience, Inc. (Nasdaq: INVO ) reported its fourth quarter and full year 2023 financial results and provided a business update. Full year revenue increased 267%, to $3,020,575, compared to $822,196 ...

2024-04-16 17:17:25 ET More on INVO BioScience NAYA Biosciences to buy gene therapy company Florida Biotechnologies Seeking Alpha’s Quant Rating on INVO BioScience Historical earnings data for INVO BioScience Financial information for INVO BioScience ...

SARASOTA, Fla., April 16, 2024 (GLOBE NEWSWIRE) -- INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a healthcare services fertility company focused on expanding access to advanced treatment worldwide through the establishment and acquisition of fertility clinics, and with the intra...

2024-01-23 08:14:16 ET More on INVO BioScience INVO, NAYA announce new board members ahead of merger Seeking Alpha’s Quant Rating on INVO BioScience Historical earnings data for INVO BioScience Financial information for INVO BioScience Read t...

NAYA to accelerate Phase II clinical development and Early Patient Access after initial safety demonstrated in 28-patient clinical trial Program developed by Florida Biotechnologies, Inc. & the University of Miami’s Bascom Palmer Eye Institute NAYA continuing to implement acqui...

2024-01-17 12:48:13 ET More on INVO BioScience Invo to acquire Naya Biosciences in all-stock deal Seeking Alpha’s Quant Rating on INVO BioScience Historical earnings data for INVO BioScience Financial information for INVO BioScience For further...

INVO (NASDAQ: INVO ) and NAYA Biosciences expect to close their previously announced merger in the first quarter of 2024 Experienced, entrepreneurial leadership team to help structure merged public company and accelerate growth SARASOTA, Fla. and AVENTURA, Fla., Jan. 17, 2024 (GLOBE...

NAYA Biosciences Announces Publication of New Data for its CD38-targeted Flex-NK™ Bispecific Antibody in the American Society of Hematology's Blood Journal PR Newswire Abstract from 2023 American Society of Hematology (ASH) Meeting Data demonstrates differentiated p...

2023-12-06 14:49:43 ET More on INVO BioScience Invo to acquire Naya Biosciences in all-stock deal Seeking Alpha’s Quant Rating on INVO BioScience Historical earnings data for INVO BioScience Financial information for INVO BioScience For further...